Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Asperguo procumbens L. versus fluoxetine for major depressive disorder
IRCT138709051457N2Phase 2Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Apr 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fluoxetine in major depressive disorder (MDD), sponsored by Mazandaran University of Medical Sciences. Started Apr 2005; status: completed.
02
Drugs
fluoxetine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on IRCT138709051457N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT138709051457N2.